AKTX - Akari Therapeutics, Plc

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
As of Date: 4/9/2020
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) 1.42
52-Week Change 3-53.85%
S&P500 52-Week Change 3-4.04%
52 Week High 35.0400
52 Week Low 30.8700
50-Day Moving Average 31.5680
200-Day Moving Average 31.7705

Share Statistics

Avg Vol (3 month) 3194.82k
Avg Vol (10 day) 3117.22k
Shares Outstanding 528.73M
Float 19.37M
% Held by Insiders 141.85%
% Held by Institutions 13.15%
Shares Short (Mar 12, 2020) 4157.73k
Short Ratio (Mar 12, 2020) 40.92
Short % of Float (Mar 12, 2020) 4N/A
Short % of Shares Outstanding (Mar 12, 2020) 40.47%
Shares Short (prior month Feb 13, 2020) 4200.34k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Sep 16, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Dec 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-142.97%
Return on Equity (ttm)-2,555.34%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -16.94M
Net Income Avi to Common (ttm)-17.11M
Diluted EPS (ttm)-1.0000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.73M
Total Cash Per Share (mrq)0.2
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.79
Book Value Per Share (mrq)-0.08

Cash Flow Statement

Operating Cash Flow (ttm)-12.92M
Levered Free Cash Flow (ttm)-4.91M